Jean‐Marc Cisterne

1.2k total citations
17 papers, 989 citations indexed

About

Jean‐Marc Cisterne is a scholar working on Hepatology, Epidemiology and Transplantation. According to data from OpenAlex, Jean‐Marc Cisterne has authored 17 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 7 papers in Epidemiology and 6 papers in Transplantation. Recurrent topics in Jean‐Marc Cisterne's work include Hepatitis C virus research (9 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Liver Disease Diagnosis and Treatment (4 papers). Jean‐Marc Cisterne is often cited by papers focused on Hepatitis C virus research (9 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Liver Disease Diagnosis and Treatment (4 papers). Jean‐Marc Cisterne collaborates with scholars based in France, Poland and United States. Jean‐Marc Cisterne's co-authors include Lionel Rostaing, D. Durand, Georges Mourad, Lars Wramner, Josep M. Campistol, Henri Kreis, W. Land, Daniel Abramowicz, P Vialtel and Jean‐Paul Squifflet and has published in prestigious journals such as The Journal of Infectious Diseases, American Journal of Kidney Diseases and Transplantation.

In The Last Decade

Jean‐Marc Cisterne

17 papers receiving 960 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Marc Cisterne France 12 544 404 366 265 151 17 989
Bettina J. Steffen United States 12 398 0.7× 191 0.5× 232 0.6× 351 1.3× 144 1.0× 12 724
Anne Modesto France 14 342 0.6× 192 0.5× 156 0.4× 200 0.8× 70 0.5× 31 855
J. Miller United States 18 513 0.9× 139 0.3× 187 0.5× 731 2.8× 86 0.6× 101 1.1k
Susanne Rockenschaub Austria 11 422 0.8× 126 0.3× 211 0.6× 449 1.7× 59 0.4× 16 781
Hamid Shidban United States 8 367 0.7× 133 0.3× 73 0.2× 253 1.0× 76 0.5× 13 590
José María Morales Spain 12 418 0.8× 121 0.3× 77 0.2× 172 0.6× 73 0.5× 19 655
Domingo del Castillo Spain 13 918 1.7× 326 0.8× 52 0.1× 498 1.9× 262 1.7× 21 1.3k
N Ahsan United States 12 190 0.3× 200 0.5× 305 0.8× 306 1.2× 51 0.3× 27 629
Mark Hathaway United Kingdom 18 300 0.6× 298 0.7× 312 0.9× 326 1.2× 18 0.1× 38 924
Mysore S. Anil Kumar United States 15 576 1.1× 156 0.4× 49 0.1× 304 1.1× 134 0.9× 24 1.0k

Countries citing papers authored by Jean‐Marc Cisterne

Since Specialization
Citations

This map shows the geographic impact of Jean‐Marc Cisterne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Marc Cisterne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Marc Cisterne more than expected).

Fields of papers citing papers by Jean‐Marc Cisterne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Marc Cisterne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Marc Cisterne. The network helps show where Jean‐Marc Cisterne may publish in the future.

Co-authorship network of co-authors of Jean‐Marc Cisterne

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Marc Cisterne. A scholar is included among the top collaborators of Jean‐Marc Cisterne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Marc Cisterne. Jean‐Marc Cisterne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Giraud, P, et al.. (2009). Néphropathie interstitielle aiguë immuno-allergique après traitement par fluindione. À propos de sept cas. Néphrologie & Thérapeutique. 5(4). 292–298. 6 indexed citations
2.
Kreis, Henri, Jean‐Marc Cisterne, W. Land, et al.. (2000). SIROLIMUS IN ASSOCIATION WITH MYCOPHENOLATE MOFETIL INDUCTION FOR THE PREVENTION OF ACUTE GRAFT REJECTION IN RENAL ALLOGRAFT RECIPIENTS12. Transplantation. 69(7). 1252–1260. 456 indexed citations
3.
Izopet, Jacques, Lionel Rostaing, Karine Sandres, et al.. (2000). Longitudinal Analysis of Hepatitis C Virus Replication and Liver Fibrosis Progression in Renal Transplant Recipients. The Journal of Infectious Diseases. 181(3). 852–858. 66 indexed citations
4.
Rostaing, Lionel, Anne Modesto, Claudine Orfila, et al.. (2000). Successful treatment of recurrence of immunotactoid glomerulopathy in a kidney allograft recipient. Nephrology Dialysis Transplantation. 15(6). 897–900. 12 indexed citations
5.
Rostaing, Lionel, Jacques Izopet, Karine Sandres, et al.. (2000). CHANGES IN HEPATITIS C VIRUS RNA VIREMIA CONCENTRATIONS IN LONG-TERM RENAL TRANSPLANT PATIENTS AFTER INTRODUCTION OF MYCOPHENOLATE MOFETIL. Transplantation. 69(5). 991–994. 61 indexed citations
6.
Rostaing, Lionel, Jacques Izopet, Catherine Arnaud, et al.. (1999). LONG-TERM IMPACT OF SUPERINFECTION BY HEPATITIS G VIRUS IN HEPATITIS C VIRUS-POSITIVE RENAL TRANSPLANT PATIENTS. Transplantation. 67(4). 556–560. 12 indexed citations
7.
Rostaing, Lionel, Jean Tkaczuk, Carlos A. Peres, et al.. (1999). Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients. Clinical Transplantation. 13(5). 400–409. 47 indexed citations
8.
Rostaing, Lionel, et al.. (1999). Predicting Factors of Long-Term Results of OKT3 Therapy for Steroid Resistant Acute Rejection following Cadaveric Renal Transplantation. American Journal of Nephrology. 19(6). 634–640. 4 indexed citations
9.
Rostaing, Lionel, Jacques Izopet, Jean‐Marc Cisterne, et al.. (1998). IMPACT OF HEPATITIS C VIRUS DURATION AND HEPATITIS C VIRUS GENOTYPES ON RENAL TRANSPLANT PATIENTS. Transplantation. 65(7). 930–936. 33 indexed citations
10.
Rostaing, Lionel, et al.. (1997). Prevalence of Antibodies to Hepatitis C Virus and Correlation with Liver Disease in Renal Transplant Patients. American Journal of Nephrology. 17(1). 46–52. 13 indexed citations
11.
Rostaing, Lionel, Sabine Henry, Jean‐Marc Cisterne, et al.. (1997). EFFICACY AND SAFETY OF LAMIVUDINE ON REPLICATION OF RECURRENT HEPATITIS B AFTER CADAVERIC RENAL TRANSPLANTATION. Transplantation. 64(11). 1624–1627. 89 indexed citations
12.
Rostaing, Lionel, et al.. (1997). Outcome of patients with antineutrophil cytoplasmic autoantibody—associated vasculitis following cadaveric kidney transplantation. American Journal of Kidney Diseases. 29(1). 96–102. 40 indexed citations
13.
Rostaing, Lionel, et al.. (1997). CMV Prophylaxis in High-Risk Renal Transplant Patients (D+/R-) by Acγclovir with or without Hyperimmune (CMV) Immunoglobulins: A Prospective Study. American Journal of Nephrology. 17(6). 489–494. 10 indexed citations
14.
Rostaing, Lionel, Jacques Izopet, Jean‐Marc Cisterne, et al.. (1996). Treatment of Chronic Hepatitis B and C with Alpha Interferon in a Renal Transplant Patient. Scandinavian Journal of Urology and Nephrology. 30(6). 485–487. 4 indexed citations
15.
Rostaing, Lionel, et al.. (1996). Acute Renal Failure in Kidney Transplant Patients Treated with Interferon Alpha 2b for Chronic Hepatitis C. Nephron. 74(3). 512–516. 109 indexed citations
16.
Rostaing, Lionel, F Oksman, Jacques Izopet, et al.. (1996). Serological Markers of Autoimmunity in Renal Transplant Patients before and after Alpha-interferon Therapy for Chronic Hepatitis C. American Journal of Nephrology. 16(6). 478–483. 11 indexed citations
17.
Cisterne, Jean‐Marc, et al.. (1995). COURSE OF HEMOPHAGOCYTIC HISTIOCYTIC SYNDROME IN RENAL TRANSPLANT PATIENTS. Transplantation. 60(5). 506–509. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bettina J. Steffen Breakdown of academic impact, for papers by Anne Modesto Breakdown of academic impact, for papers by J. Miller Breakdown of academic impact, for papers by Susanne Rockenschaub Breakdown of academic impact, for papers by Hamid Shidban Breakdown of academic impact, for papers by José María Morales Breakdown of academic impact, for papers by Domingo del Castillo Breakdown of academic impact, for papers by N Ahsan Breakdown of academic impact, for papers by Mark Hathaway Breakdown of academic impact, for papers by Mysore S. Anil Kumar
Rankless by CCL
2026